Novozymes A/S
DUS:NZM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novozymes A/S
DUS:NZM2
|
DK |
|
Invesco Ltd
NYSE:IVZ
|
US |
|
Unibail-Rodamco-Westfield SE
ASX:URW
|
FR |
|
GHCL Ltd
NSE:GHCL
|
IN |
|
Cbrain A/S
CSE:CBRAIN
|
DK |
|
B
|
Bel Fuse Inc
NASDAQ:BELFB
|
US |
|
Lumibird SA
PAR:LBIRD
|
FR |
|
T
|
Teradyne Inc
F:TEY
|
US |
|
Green Cross Holdings
KRX:005250
|
KR |
|
Dillard's Inc
NYSE:DDS
|
US |
|
H
|
Healius Ltd
ASX:HLS
|
AU |
|
Stellantis NV
MIL:STLAM
|
NL |
|
Mapletree Pan Asia Commercial Trust
SGX:N2IU
|
SG |
|
JBM Auto Ltd
NSE:JBMA
|
IN |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
SA |
|
NTG Nordic Transport Group AS
CSE:NTG
|
DK |
|
Markel Corp
NYSE:MKL
|
US |
Wall St Price Targets
NZM2 Price Targets Summary
Novozymes A/S
According to Wall Street analysts, the average 1-year price target for NZM2 is 63.37 EUR with a low forecast of 51.3 EUR and a high forecast of 77.47 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM2's stock price target?
Price Target
63.37
EUR
According to Wall Street analysts, the average 1-year price target for NZM2 is 63.37 EUR with a low forecast of 51.3 EUR and a high forecast of 77.47 EUR.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
